Home/Filings/4/0001415889-23-016322
4//SEC Filing

Kovacs Shane William Charles 4

Accession 0001415889-23-016322

CIK 0001750284other

Filed

Dec 11, 7:00 PM ET

Accepted

Dec 12, 5:55 PM ET

Size

6.9 KB

Accession

0001415889-23-016322

Insider Transaction Report

Form 4
Period: 2023-12-12
Kovacs Shane William Charles
CH. OPERATING & FINANCIAL OFF.
Transactions
  • Exercise/Conversion

    Common Stock

    2023-12-12$7.02/sh+10,000$70,200434,987 total
  • Exercise/Conversion

    Stock Option (Right to Buy)

    2023-12-1210,000237,000 total
    Exercise: $7.02Exp: 2032-01-31Common Stock (10,000 underlying)
Footnotes (1)
  • [F1]25% of the shares subject to the option vested on February 1, 2023 and 1/48 of the total number of shares subject to the option vest each month thereafter, subject to the Reporting Person's continuous service through each applicable vesting date.

Issuer

Olema Pharmaceuticals, Inc.

CIK 0001750284

Entity typeother

Related Parties

1
  • filerCIK 0001579397

Filing Metadata

Form type
4
Filed
Dec 11, 7:00 PM ET
Accepted
Dec 12, 5:55 PM ET
Size
6.9 KB